Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $68 at Credit Suisse; Sees Multiple Catalysts Ahead

February 5, 2018 7:11 AM
Credit Suisse raised its price target on Merck (NYSE: MRK) to $68.00 (from $67.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles